E-ISSN: 2147-1959
Metastatic Superscan in <sup>18</sup>F PSMA PET/CT of a Patient with Prostate Carcinoma
PDF
Cite
Share
Request
Interesting Image
VOLUME: 33 ISSUE: 1
P: 38-39
February 2024

Metastatic Superscan in 18F PSMA PET/CT of a Patient with Prostate Carcinoma

Mol Imaging Radionucl Ther 2024;33(1):38-39
DOI: 10.4274/mirt.galenos.2023.68815
Man Mohan Singh
Shashwat Verma
Lavish Kakkar
Satyawati Deswal
Priyamedha Bose Thakur
1. Dr. Ram Manohar Lohia Institute of Medical Sciences, Department of Nuclear Medicine, Lucknow, India
No information available.
No information available
Received Date: 03.12.2022
Accepted Date: 02.04.2023
Publish Date: 23.02.2024
PDF
Cite
Share
Request

ABSTRACT

A biopsy-proven patient with prostate carcinoma aged 70 years was referred to the department of nuclear medicine for radionuclide-based therapy. His prostate-specific antigen levels were >1000 ng/mL, and prostatic magnetic resonance imaging showed an enlarged prostate with a heterogeneous signal and size 3.8x3.7x3.5 cm with few small heterogeneous nodular signals in the transition zone. He was scheduled for 18F prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) scan before therapy. 18F PSMA PET/CT revealed PSMA-expressing prostate lesions (maximum standardized uptake value ~10.2) with extension into the urinary bladder along with bilateral supraclavicular, mediastinal, retrocrural, retroperitoneal, and pelvic lymph nodes and sclerotic lesions in the entire axial and appendicular skeleton.

Keywords: Superscan, prostate carcinoma, 18F PSMA PET/CT, 18F prostate-specific membrane antigen

References

1
Liu Y. Super-superscan on a bone scintigraphy. Clin Nucl Med 2011;36:227-228.
2
Buckley O, O’Keeffe S, Geoghegan T, Lyburn ID, Munk PL, Worsley D, Torreggiani WC. 99mTc bone scintigraphy superscans: a review. Nucl Med Commun 2007;28:521-527.
3
Chan M, Schembri GP. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT “superscan” in metastatic pancreatic neuroendocrine tumor. Clin Nucl Med 2017;42:108-109.
4
Chakraborty PS, Sharma P, Karunanithi S, Bal C, Kumar R. Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology. Indian J Nucl Med 2014;29:158-159.
5
Agarwal KK, Tripathi M, Kumar R, Bal C. Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan. Indian J Nucl Med 2016;31:150-151.
6
Awenat S, Piccardo A, Carvoeiras P, Signore G, Giovanella L, Prior JO, Treglia G. Diagnostic role of 18F-PSMA-1007 PET/CT in prostate cancer staging: a systematic review. Diagnostics (Basel) 2021;11:552.
7
Ferrari M, Treglia G. 18F-PSMA-1007 pET in biochemical recurrent prostate cancer: an updated meta-analysis. Contrast Media Mol Imaging 2021;2021:3502389.
8
Wang Z, Zheng A, Li Y, Dong W, Liu X, Yuan W, Gao F, Duan X. 18F-PSMA-1007 PET/CT performance on risk stratification discrimination and distant metastases prediction in newly diagnosed prostate cancer. Front Oncol 2021;11:759053.
2024 ©️ Galenos Publishing House